Literature DB >> 53018

Nonspecific reactions with the intradermal test for hydatidosis in persons with other helminth infections.

P M Schantz, R E Ortiz-Valqui, H Lumbreras.   

Abstract

A partially purified Echinococcus antigen solution, prepared by boiling hydatid cyst fluid, was used in the intradermal test for hydatid disease in a Peruvian population. An unexpectedly high rate of positive reactions and poor agreement with serological tests suggested the presence of some agent(s) which produced cross-reactions with Echinococcus granulosus antigens in the intradermal test. Testing of hospital patients infected with a variety of helminths demonstrated nonspecific reactions in persons with Hymenolepis nana, Taenia spp., and Fasciola hepatica infections, mixed parasitisms, and several non-helminth pathological conditions. The findings contraindicated the use of the intradermal test for epidemiological surveys of hydatid disease. It is pointed out that intradermal test positivity rates cannot be used as synonymous with infection prevalence and regional differences do not necessarily reflect differences in the prevalence of E. granulosus infection. The greater specificity of some serological tests favor their use for epidemiological purposes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53018     DOI: 10.4269/ajtmh.1975.24.849

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Specific recognition of hydatid cyst antigens by serum IgG, IgE, and IgA using western blot.

Authors:  Y Sbihi; D Janssen; A Osuna
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Immunoreactivity in pulmonary echinococcosis. A comparative study of immunodiagnostic tests.

Authors:  T Todorov; I Dakov; M Kosturkova; S Tenev; A Dimitrov
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

3.  Diagnostic value of a synthetic peptide derived from Echinococcus granulosus recombinant protein.

Authors:  M Chamekh; H Gras-Masse; M Bossus; B Facon; C Dissous; A Tartar; A Capron
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.